UNSPSC 41131810: Russell viper venom reagent

In this classification a Russell viper venom reagent is a device used to determine the cause of an increase in the prothrombin time US FDA regulates Russell viper venom reagent under 21 CFR 864.8950 and under FDA product code GIR.

UNSPSC 41131810 Russell viper venom reagent is a Commodity code that in current state and local procurement activity covers laboratory hematology and chemistry testing systems, proficiency testing samples, and analytical instrument consumables supporting blood analysis and screening applications. State and local solicitations under this code reflect procurement of specialized diagnostic equipment and supplies used in public health laboratory operations, particularly for hemoglobin analysis, whole blood chemistry proficiency testing, and trace-element blood screening. Issuing bodies include state health and human services departments and university laboratory procurement offices, with the Texas Health and Human Services Commission (HHSC) and Department of State Health Services appearing as repeat buyers of diagnostic laboratory equipment and supplies.

Recent activity centers in Texas and Wisconsin. The Texas HHSC and DSHS issued an Invitation for Bids (IFB) in May 2026 (solicitation HHS0017310, response deadline May 18, 2026) for a D-10 Hemoglobin Testing System with Rack Loader for the South Texas Lab in Harlingen, with historical spending guidance of $45,050 to $80,000. The same HHSC division posted an IFB in March 2026 (HHS0017071, due March 5, 2026) for PerkinElmer ICP-MS consumables and supplies—sample probes, filters, cones, nebulizers, torches, tubing, and solutions—for pediatric blood lead screening, with historical spend of $20,000 to $30,000. The University of Wisconsin-Madison solicited competitive bids in April 2026 (ShopUW+ Event 2026-UWMSN-01287-RFB, due May 5, 2026) for custom-made hematology and whole blood chemistry proficiency testing samples. All three solicitations are open competitive procurements with no set-aside designations, firm-and-fixed pricing requirements, and best-value evaluation criteria.